Top

Category: Vaccines


Industry, Vaccines

AZD1222 vaccine met primary efficacy endpoint in preventing COVID-19

November 23, 2020

Via: World Pharma News

Positive high-level results from an interim analysis of clinical trials of AZD1222 in the UK and Brazil showed the vaccine was highly effective in preventing COVID-19, the primary endpoint, and no hospitalisations or severe cases of the disease were reported […]


Industry, Vaccines

Pfizer and BioNTech request emergency authorization from FDA for Covid vaccine

November 20, 2020

Via: CNBC

Pfizer and BioNTech on Friday applied for an emergency use authorization from the Food and Drug Administration for their coronavirus vaccine. If Pfizer’s application is approved, the vaccine will likely be limited and rolled out in phases, with health-care workers, […]


Industry, Vaccines

Hospitals scramble to get ready for coronavirus vaccines

November 19, 2020

Via: Biopharma Dive

Hospitals across the country are ramping up their efforts to figure out how to store, track and administer coronavirus vaccine doses as confidence grows that an effective vaccine could soon become available. Hospitals will play a key role once a […]


Industry, News, Vaccines

Immune-Boosting Components Double the Effectiveness of Melanoma Vaccine Candidate in Phase II Trial

November 18, 2020

Via: Genetic Engineering and Biotechnology News

A vaccine created to prevent the recurrence of the deadly skin cancer melanoma is about twice as effective when patients also receive two components that boost the number and effectiveness of immune system dendritic cells (DCs), according to the results […]


Industry, Vaccines

Moderna COVID-19 Vaccine 94.5% Effective in Early Phase III Data

November 16, 2020

Via: Genetic Engineering and Biotechnology News

Moderna said today that its COVID-19 vaccine candidate mRNA-1273 passed its most important test, the 30,000+ patient Phase III COVE trial (NCT04470427), by showing itself to be 94.5% effective in preventing COVID-19—an outcome hailed by CEO Stéphane Bancel as a […]


Industry, Vaccines

BIO Chairman: FDA Vaccine Reviews Too Complex and Costly for States to Replicate

November 10, 2020

Via: BioSpace

Several states have pledged to review COVID-19 vaccines themselves, after U.S. Food and Drug Administration (FDA) Emergency Use Authorizations EUA), to ensure safety and efficacy. A robust review, however, is unlikely. In reality, if state reviews go forward, they most […]


Industry, Vaccines

Coronavirus vaccine frontrunner Pfizer delivers key trial data – here’s where the other vaccines stand

November 9, 2020

Via: CNBC

Numerous pharmaceutical companies are racing to complete clinical trials and become the first to successfully get U.S. approval for a vaccine to fight the coronavirus, which has infected more than 50.5 million people worldwide in 11 months. A safe and […]


Industry, Vaccines

COVID-19 Nanoparticle Vaccine Elicits High Levels of Protective Antibodies in Mice

November 3, 2020

Via: Genetic Engineering and Biotechnology News

There are currently hundreds of COVID-19 vaccine candidates in development around the world. Some of the challenges facing them are the requirement of large doses, complex manufacturing, and cold-chain shipping and storage. An ultrapotent vaccine that is safe, effective at […]


Industry, Vaccines

Fauci Predicts First COVID-19 Vaccine by Late December for High-Risk Americans

October 30, 2020

Via: BioSpace

Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases (NIAID), said a coronavirus vaccine may be available to high-risk Americans by the end of December or early January. Right now, four candidates are now in Phase […]


Industry, Vaccines

Trump administration to require insurers cover coronavirus vaccines

October 29, 2020

Via: Biopharma Dive

A third surge in COVID-19 cases in the U.S., with many hospital systems warning of strained capacity, underscores how much hopes for a return to normalcy could hinge on a safe and effective vaccine. More than 40 vaccines are in […]


Industry, Manufacturing, Research and Development, Vaccines

Medigene and Cytovant Sign Vaccine Manufacturing Deal

October 27, 2020

Via: Genetic Engineering and Biotechnology News

Medigene, clinical stage immuno-oncology company focusing on the development of T cell immunotherapies for cancer, entered into a service agreement with Cytovant Sciences to support process development activities for the manufacturing of dendritic cell (DC) vaccines. The deal builds on […]


Industry, Vaccines

COVID-19 vaccine biotech Vaccitech nabs Pfizer, Kite vet as full-time CMO

October 20, 2020

Via: FierceBiotech

The biotech behind AstraZeneca and the University of Oxford’s late-stage pandemic vaccine has hired Margaret (Meg) Marshall, M.D., as its new chief medical officer. Marshall joined as a consultant to Oxford spinout Vaccitech in the summer, but she now jumps […]